PharmAbcine Founder Calls For Post-Delisting Protections For Korean Biotechs

Urges Special Regulations To Protect Assets

 
• By Jung Won Shin
  
Korean stock market
Yoo Proposes New Regulation To Safeguard Core Assets, Stakeholders After Delisting (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business